Cargando…
Respiratory viral diseases: access to RNA interference therapy
This review summarizes recent experimental achievements in the area of the development of new RNA interference (RNAi) therapeutics for the treatment of viral respiratory diseases. Delivery of short interfering RNA (siRNA) to their intended target tissue remains the biggest problem for most therapeut...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597863/ https://www.ncbi.nlm.nih.gov/pubmed/19081824 http://dx.doi.org/10.1016/j.ddstr.2008.01.001 |